TLNC TLNC
Company Profile ↓Company Overview
TLNC (TLNC) is a publicly traded company listed on with a market capitalization of $347.94M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | +3.43% |
| 6 Months: | +0.99% |
| 3 Months: | +0.69% |
| 1 Month: | -1.25% |
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)40.43 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Revenue | - | 0 | 0 |
| Cost of Revenue | - | - | - |
| Gross Profit | - | - | - |
| Operating Expenses | - | 233.10K | 342.81K |
| Operating Income | -37.26K | -233.10K | -342.81K |
| EBITDA | - | -233.10K | -342.81K |
| Interest Expense | - | - | - |
| Pretax Income | - | 383.94K | 1.97M |
| Tax Provision | - | - | - |
| Net Income | -37.26K | 383.94K | 1.97M |
| Diluted EPS | 0.00 | 0.03 | 0.06 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2025 |
|---|---|
| Total Assets | 255.10M |
| Current Assets | 2.95M |
| Cash & Equivalents | 2.87M |
| Inventory | - |
| Receivables | - |
| Total Liabilities | 10.33M |
| Current Liabilities | 128.70K |
| Long Term Debt | - |
| Total Debt | - |
| Total Equity | 244.77M |
| Shares Outstanding | 33.98M |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for TLNC
Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies
Oricell Therapeutics Holdings Limited ("Oricell"), a global clinical-stage biotechnology company pioneering innovative cancer immunotherapies, today announced the cumulative closing of a pre-IPO financing round in excess of $110 million. Th…
Oricell Therapeutics Announces US$70M Initial Closing of Series C Financing, to Accelerate Global Development of Solid Tumor CAR-T Therapies
Oricell Therapeutics Holdings Limited ("Oricell" or "the Company"), a global leader in innovative cancer immunotherapy, announced today the closing of a $70M Series C1 financing.
TLNC — Frequently Asked Questions
What is the current share price of TLNC?
As of 2026-08-05 17:25 PDT, TLNC trades at $10.24 on NASDAQ/NYSE. Its 52-week range is $9.90 to $10.38.
What is the market capitalisation of TLNC?
TLNC has a market capitalisation of $347.94M on NASDAQ/NYSE.
Is TLNC a good stock to buy?
This page provides a data-driven analysis of TLNC, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.